Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2022 | Story Rulanzen Martin | Photo Supplied
Dr Sello Thinane
Dr Jonas Thinane graduated with a PhD from the University of South Africa.

Dr Jonas Thinane, who recently obtained his PhD in Theology from the University of South Africa (Unisa), has been working in the Department of Hebrew since his first year as a Theology student; he is currently employed as departmental administrator in the department. 

It was his diligence and comments that convinced Prof Cynthia Miller-Naude to offer him employment as student assistant in the department.  His work involves overseeing the administration of three entwined units within the department.  “I am really proud of all that he has accomplished since then, seizing every opportunity available for learning and growing, without allowing obstacles to block his path,” said Prof Miller-Naude. 

His PhD focused on Human rights abuse by some self-styled spiritual leaders within the ‘Nyaope religion’ in South Africa and was supervised by Prof MS Kgatle from the Department of Christian Spirituality, Church History and Missiology at Unisa. 

An avid academic and researcher 

Apart from the research he undertook to complete his PhD in less than two years, he published nine accredited articles and a chapter in a book between 2021 and 2022. “I currently have six articles undergoing peer review and am working on more to publish in local and international journals this year,” says Dr Thinane. 

Dr Thinane’s research specialisation lies within Missiology, where he has introduced new knowledge to the subject matter through extensive writing on concepts of missio hominum (mission of human beings) in relation to the broader setting of the Missio Dei (Mission of God). “Beyond this, some of my published articles cover broad yet relevant topics such as COVID-19 and vaccine challenges in South Africa, the question of mandatory vaccination from a religious perspective, the ANC step-aside rule in conflict with Thuma Mina objectives, and many other topics relevant to our current challenges in South Africa,” Dr Thinane says. 

“I am sure that he will make a great contribution to academia for the benefit of society in the future,” says Prof Miller-Naude. 

Support and motivation from department 

Dr Thinane is very appreciative of the support he received from the department throughout his PhD journey. 
This is indeed a great achievement within the scope of the UFS’ encouragement for publication on subjects that greatly contribute to the cognition and advancement of our society.
Dr Thinane graduation
From the left: Dr KJ Padi (UFS Practical and Missional Theology), Dr A Motsei (UFS African Languages), Dr JS Thinane (Department of Hebrew),
Dr M Choane (UFS Political Studies and Governance), Prof MS Kgatle (UNISA Department of Christian Spirituality, Church History and Missiology),
Dr ME Maibi (UFS alumnus). (Photo: Supplied)

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept